Industry Research Reports
Home > Reports > Service & Software > Global Biopharmaceutical Testing Services Market Research Report 2025
Global Biopharmaceutical Testing Services Market Research Report 2025
Industry: Service & Software
Published Date: 2025-02-20
Pages: 95 Pages
Report ld: 4016341
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Biopharmaceutical Testing Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical Testing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical Testing Services.
The Biopharmaceutical Testing Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biopharmaceutical Testing Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceutical Testing Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
By Company
- Eurofins Scientific
- SGS
- Envigo
- Exova Group
- PPD Inc.
- Pace Analytical Services
- Intertek Group
- DYNALABS
- RD Laboratories
- West Pharmaceutical Services
- Polymer Solutions
- Boston Analytical
- Accuratus Labs
- Microbac
- ARLBioPharma
- Lapuck Laboratories
- BioScreen
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Raw Materials Testing
- In-Process and Product Release Testing
- Finished Pharmaceutical Products Testing
- Environmental Samples
- Others
Segment by Application
- Hospitals
- Clinics
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceutical Testing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical Testing Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Raw Materials Testing
1.2.3 In-Process and Product Release Testing
1.2.4 Finished Pharmaceutical Products Testing
1.2.5 Environmental Samples
1.2.6 Others
1.3 Market by Application
1.3.1 Global Biopharmaceutical Testing Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical Testing Services Market Perspective (2020-2031)
2.2 Global Biopharmaceutical Testing Services Growth Trends by Region
2.2.1 Global Biopharmaceutical Testing Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biopharmaceutical Testing Services Historic Market Size by Region (2020-2025)
2.2.3 Biopharmaceutical Testing Services Forecasted Market Size by Region (2026-2031)
2.3 Biopharmaceutical Testing Services Market Dynamics
2.3.1 Biopharmaceutical Testing Services Industry Trends
2.3.2 Biopharmaceutical Testing Services Market Drivers
2.3.3 Biopharmaceutical Testing Services Market Challenges
2.3.4 Biopharmaceutical Testing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical Testing Services Players by Revenue
3.1.1 Global Top Biopharmaceutical Testing Services Players by Revenue (2020-2025)
3.1.2 Global Biopharmaceutical Testing Services Revenue Market Share by Players (2020-2025)
3.2 Global Biopharmaceutical Testing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biopharmaceutical Testing Services Revenue
3.4 Global Biopharmaceutical Testing Services Market Concentration Ratio
3.4.1 Global Biopharmaceutical Testing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Testing Services Revenue in 2024
3.5 Global Key Players of Biopharmaceutical Testing Services Head office and Area Served
3.6 Global Key Players of Biopharmaceutical Testing Services, Product and Application
3.7 Global Key Players of Biopharmaceutical Testing Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical Testing Services Breakdown Data by Type
4.1 Global Biopharmaceutical Testing Services Historic Market Size by Type (2020-2025)
4.2 Global Biopharmaceutical Testing Services Forecasted Market Size by Type (2026-2031)
5 Biopharmaceutical Testing Services Breakdown Data by Application
5.1 Global Biopharmaceutical Testing Services Historic Market Size by Application (2020-2025)
5.2 Global Biopharmaceutical Testing Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biopharmaceutical Testing Services Market Size (2020-2031)
6.2 North America Biopharmaceutical Testing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biopharmaceutical Testing Services Market Size by Country (2020-2025)
6.4 North America Biopharmaceutical Testing Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biopharmaceutical Testing Services Market Size (2020-2031)
7.2 Europe Biopharmaceutical Testing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biopharmaceutical Testing Services Market Size by Country (2020-2025)
7.4 Europe Biopharmaceutical Testing Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical Testing Services Market Size (2020-2031)
8.2 Asia-Pacific Biopharmaceutical Testing Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biopharmaceutical Testing Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Biopharmaceutical Testing Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biopharmaceutical Testing Services Market Size (2020-2031)
9.2 Latin America Biopharmaceutical Testing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biopharmaceutical Testing Services Market Size by Country (2020-2025)
9.4 Latin America Biopharmaceutical Testing Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical Testing Services Market Size (2020-2031)
10.2 Middle East & Africa Biopharmaceutical Testing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biopharmaceutical Testing Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Biopharmaceutical Testing Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Details
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific Biopharmaceutical Testing Services Introduction
11.1.4 Eurofins Scientific Revenue in Biopharmaceutical Testing Services Business (2020-2025)
11.1.5 Eurofins Scientific Recent Development
11.2 SGS
11.2.1 SGS Company Details
11.2.2 SGS Business Overview
11.2.3 SGS Biopharmaceutical Testing Services Introduction
11.2.4 SGS Revenue in Biopharmaceutical Testing Services Business (2020-2025)
11.2.5 SGS Recent Development
11.3 Envigo
11.3.1 Envigo Company Details
11.3.2 Envigo Business Overview
11.3.3 Envigo Biopharmaceutical Testing Services Introduction
11.3.4 Envigo Revenue in Biopharmaceutical Testing Services Business (2020-2025)
11.3.5 Envigo Recent Development
11.4 Exova Group
11.4.1 Exova Group Company Details
11.4.2 Exova Group Business Overview
11.4.3 Exova Group Biopharmaceutical Testing Services Introduction
11.4.4 Exova Group Revenue in Biopharmaceutical Testing Services Business (2020-2025)
11.4.5 Exova Group Recent Development
11.5 PPD Inc.
11.5.1 PPD Inc. Company Details
11.5.2 PPD Inc. Business Overview
11.5.3 PPD Inc. Biopharmaceutical Testing Services Introduction
11.5.4 PPD Inc. Revenue in Biopharmaceutical Testing Services Business (2020-2025)
11.5.5 PPD Inc. Recent Development
11.6 Pace Analytical Services
11.6.1 Pace Analytical Services Company Details
11.6.2 Pace Analytical Services Business Overview
11.6.3 Pace Analytical Services Biopharmaceutical Testing Services Introduction
11.6.4 Pace Analytical Services Revenue in Biopharmaceutical Testing Services Business (2020-2025)
11.6.5 Pace Analytical Services Recent Development
11.7 Intertek Group
11.7.1 Intertek Group Company Details
11.7.2 Intertek Group Business Overview
11.7.3 Intertek Group Biopharmaceutical Testing Services Introduction
11.7.4 Intertek Group Revenue in Biopharmaceutical Testing Services Business (2020-2025)
11.7.5 Intertek Group Recent Development
11.8 DYNALABS
11.8.1 DYNALABS Company Details
11.8.2 DYNALABS Business Overview
11.8.3 DYNALABS Biopharmaceutical Testing Services Introduction
11.8.4 DYNALABS Revenue in Biopharmaceutical Testing Services Business (2020-2025)
11.8.5 DYNALABS Recent Development
11.9 RD Laboratories
11.9.1 RD Laboratories Company Details
11.9.2 RD Laboratories Business Overview
11.9.3 RD Laboratories Biopharmaceutical Testing Services Introduction
11.9.4 RD Laboratories Revenue in Biopharmaceutical Testing Services Business (2020-2025)
11.9.5 RD Laboratories Recent Development
11.10 West Pharmaceutical Services
11.10.1 West Pharmaceutical Services Company Details
11.10.2 West Pharmaceutical Services Business Overview
11.10.3 West Pharmaceutical Services Biopharmaceutical Testing Services Introduction
11.10.4 West Pharmaceutical Services Revenue in Biopharmaceutical Testing Services Business (2020-2025)
11.10.5 West Pharmaceutical Services Recent Development
11.11 Polymer Solutions
11.11.1 Polymer Solutions Company Details
11.11.2 Polymer Solutions Business Overview
11.11.3 Polymer Solutions Biopharmaceutical Testing Services Introduction
11.11.4 Polymer Solutions Revenue in Biopharmaceutical Testing Services Business (2020-2025)
11.11.5 Polymer Solutions Recent Development
11.12 Boston Analytical
11.12.1 Boston Analytical Company Details
11.12.2 Boston Analytical Business Overview
11.12.3 Boston Analytical Biopharmaceutical Testing Services Introduction
11.12.4 Boston Analytical Revenue in Biopharmaceutical Testing Services Business (2020-2025)
11.12.5 Boston Analytical Recent Development
11.13 Accuratus Labs
11.13.1 Accuratus Labs Company Details
11.13.2 Accuratus Labs Business Overview
11.13.3 Accuratus Labs Biopharmaceutical Testing Services Introduction
11.13.4 Accuratus Labs Revenue in Biopharmaceutical Testing Services Business (2020-2025)
11.13.5 Accuratus Labs Recent Development
11.14 Microbac
11.14.1 Microbac Company Details
11.14.2 Microbac Business Overview
11.14.3 Microbac Biopharmaceutical Testing Services Introduction
11.14.4 Microbac Revenue in Biopharmaceutical Testing Services Business (2020-2025)
11.14.5 Microbac Recent Development
11.15 ARLBioPharma
11.15.1 ARLBioPharma Company Details
11.15.2 ARLBioPharma Business Overview
11.15.3 ARLBioPharma Biopharmaceutical Testing Services Introduction
11.15.4 ARLBioPharma Revenue in Biopharmaceutical Testing Services Business (2020-2025)
11.15.5 ARLBioPharma Recent Development
11.16 Lapuck Laboratories
11.16.1 Lapuck Laboratories Company Details
11.16.2 Lapuck Laboratories Business Overview
11.16.3 Lapuck Laboratories Biopharmaceutical Testing Services Introduction
11.16.4 Lapuck Laboratories Revenue in Biopharmaceutical Testing Services Business (2020-2025)
11.16.5 Lapuck Laboratories Recent Development
11.17 BioScreen
11.17.1 BioScreen Company Details
11.17.2 BioScreen Business Overview
11.17.3 BioScreen Biopharmaceutical Testing Services Introduction
11.17.4 BioScreen Revenue in Biopharmaceutical Testing Services Business (2020-2025)
11.17.5 BioScreen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Biopharmaceutical Testing Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Raw Materials Testing
Table 3. Key Players of In-Process and Product Release Testing
Table 4. Key Players of Finished Pharmaceutical Products Testing
Table 5. Key Players of Environmental Samples
Table 6. Key Players of Others
Table 7. Global Biopharmaceutical Testing Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Biopharmaceutical Testing Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Biopharmaceutical Testing Services Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Biopharmaceutical Testing Services Market Share by Region (2020-2025)
Table 11. Global Biopharmaceutical Testing Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Biopharmaceutical Testing Services Market Share by Region (2026-2031)
Table 13. Biopharmaceutical Testing Services Market Trends
Table 14. Biopharmaceutical Testing Services Market Drivers
Table 15. Biopharmaceutical Testing Services Market Challenges
Table 16. Biopharmaceutical Testing Services Market Restraints
Table 17. Global Biopharmaceutical Testing Services Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Biopharmaceutical Testing Services Market Share by Players (2020-2025)
Table 19. Global Top Biopharmaceutical Testing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Testing Services as of 2024)
Table 20. Ranking of Global Top Biopharmaceutical Testing Services Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Biopharmaceutical Testing Services Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Biopharmaceutical Testing Services, Headquarters and Area Served
Table 23. Global Key Players of Biopharmaceutical Testing Services, Product and Application
Table 24. Global Key Players of Biopharmaceutical Testing Services, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Biopharmaceutical Testing Services Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Biopharmaceutical Testing Services Revenue Market Share by Type (2020-2025)
Table 28. Global Biopharmaceutical Testing Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Biopharmaceutical Testing Services Revenue Market Share by Type (2026-2031)
Table 30. Global Biopharmaceutical Testing Services Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Biopharmaceutical Testing Services Revenue Market Share by Application (2020-2025)
Table 32. Global Biopharmaceutical Testing Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Biopharmaceutical Testing Services Revenue Market Share by Application (2026-2031)
Table 34. North America Biopharmaceutical Testing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Biopharmaceutical Testing Services Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Biopharmaceutical Testing Services Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Biopharmaceutical Testing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Biopharmaceutical Testing Services Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Biopharmaceutical Testing Services Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Biopharmaceutical Testing Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Biopharmaceutical Testing Services Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Biopharmaceutical Testing Services Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Biopharmaceutical Testing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Biopharmaceutical Testing Services Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Biopharmaceutical Testing Services Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Biopharmaceutical Testing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Biopharmaceutical Testing Services Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Biopharmaceutical Testing Services Market Size by Country (2026-2031) & (US$ Million)
Table 49. Eurofins Scientific Company Details
Table 50. Eurofins Scientific Business Overview
Table 51. Eurofins Scientific Biopharmaceutical Testing Services Product
Table 52. Eurofins Scientific Revenue in Biopharmaceutical Testing Services Business (2020-2025) & (US$ Million)
Table 53. Eurofins Scientific Recent Development
Table 54. SGS Company Details
Table 55. SGS Business Overview
Table 56. SGS Biopharmaceutical Testing Services Product
Table 57. SGS Revenue in Biopharmaceutical Testing Services Business (2020-2025) & (US$ Million)
Table 58. SGS Recent Development
Table 59. Envigo Company Details
Table 60. Envigo Business Overview
Table 61. Envigo Biopharmaceutical Testing Services Product
Table 62. Envigo Revenue in Biopharmaceutical Testing Services Business (2020-2025) & (US$ Million)
Table 63. Envigo Recent Development
Table 64. Exova Group Company Details
Table 65. Exova Group Business Overview
Table 66. Exova Group Biopharmaceutical Testing Services Product
Table 67. Exova Group Revenue in Biopharmaceutical Testing Services Business (2020-2025) & (US$ Million)
Table 68. Exova Group Recent Development
Table 69. PPD Inc. Company Details
Table 70. PPD Inc. Business Overview
Table 71. PPD Inc. Biopharmaceutical Testing Services Product
Table 72. PPD Inc. Revenue in Biopharmaceutical Testing Services Business (2020-2025) & (US$ Million)
Table 73. PPD Inc. Recent Development
Table 74. Pace Analytical Services Company Details
Table 75. Pace Analytical Services Business Overview
Table 76. Pace Analytical Services Biopharmaceutical Testing Services Product
Table 77. Pace Analytical Services Revenue in Biopharmaceutical Testing Services Business (2020-2025) & (US$ Million)
Table 78. Pace Analytical Services Recent Development
Table 79. Intertek Group Company Details
Table 80. Intertek Group Business Overview
Table 81. Intertek Group Biopharmaceutical Testing Services Product
Table 82. Intertek Group Revenue in Biopharmaceutical Testing Services Business (2020-2025) & (US$ Million)
Table 83. Intertek Group Recent Development
Table 84. DYNALABS Company Details
Table 85. DYNALABS Business Overview
Table 86. DYNALABS Biopharmaceutical Testing Services Product
Table 87. DYNALABS Revenue in Biopharmaceutical Testing Services Business (2020-2025) & (US$ Million)
Table 88. DYNALABS Recent Development
Table 89. RD Laboratories Company Details
Table 90. RD Laboratories Business Overview
Table 91. RD Laboratories Biopharmaceutical Testing Services Product
Table 92. RD Laboratories Revenue in Biopharmaceutical Testing Services Business (2020-2025) & (US$ Million)
Table 93. RD Laboratories Recent Development
Table 94. West Pharmaceutical Services Company Details
Table 95. West Pharmaceutical Services Business Overview
Table 96. West Pharmaceutical Services Biopharmaceutical Testing Services Product
Table 97. West Pharmaceutical Services Revenue in Biopharmaceutical Testing Services Business (2020-2025) & (US$ Million)
Table 98. West Pharmaceutical Services Recent Development
Table 99. Polymer Solutions Company Details
Table 100. Polymer Solutions Business Overview
Table 101. Polymer Solutions Biopharmaceutical Testing Services Product
Table 102. Polymer Solutions Revenue in Biopharmaceutical Testing Services Business (2020-2025) & (US$ Million)
Table 103. Polymer Solutions Recent Development
Table 104. Boston Analytical Company Details
Table 105. Boston Analytical Business Overview
Table 106. Boston Analytical Biopharmaceutical Testing Services Product
Table 107. Boston Analytical Revenue in Biopharmaceutical Testing Services Business (2020-2025) & (US$ Million)
Table 108. Boston Analytical Recent Development
Table 109. Accuratus Labs Company Details
Table 110. Accuratus Labs Business Overview
Table 111. Accuratus Labs Biopharmaceutical Testing Services Product
Table 112. Accuratus Labs Revenue in Biopharmaceutical Testing Services Business (2020-2025) & (US$ Million)
Table 113. Accuratus Labs Recent Development
Table 114. Microbac Company Details
Table 115. Microbac Business Overview
Table 116. Microbac Biopharmaceutical Testing Services Product
Table 117. Microbac Revenue in Biopharmaceutical Testing Services Business (2020-2025) & (US$ Million)
Table 118. Microbac Recent Development
Table 119. ARLBioPharma Company Details
Table 120. ARLBioPharma Business Overview
Table 121. ARLBioPharma Biopharmaceutical Testing Services Product
Table 122. ARLBioPharma Revenue in Biopharmaceutical Testing Services Business (2020-2025) & (US$ Million)
Table 123. ARLBioPharma Recent Development
Table 124. Lapuck Laboratories Company Details
Table 125. Lapuck Laboratories Business Overview
Table 126. Lapuck Laboratories Biopharmaceutical Testing Services Product
Table 127. Lapuck Laboratories Revenue in Biopharmaceutical Testing Services Business (2020-2025) & (US$ Million)
Table 128. Lapuck Laboratories Recent Development
Table 129. BioScreen Company Details
Table 130. BioScreen Business Overview
Table 131. BioScreen Biopharmaceutical Testing Services Product
Table 132. BioScreen Revenue in Biopharmaceutical Testing Services Business (2020-2025) & (US$ Million)
Table 133. BioScreen Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
Table 137. Authors List of This Report
List of Figures
Figure 1. Biopharmaceutical Testing Services Picture
Figure 2. Global Biopharmaceutical Testing Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biopharmaceutical Testing Services Market Share by Type: 2024 VS 2031
Figure 4. Raw Materials Testing Features
Figure 5. In-Process and Product Release Testing Features
Figure 6. Finished Pharmaceutical Products Testing Features
Figure 7. Environmental Samples Features
Figure 8. Others Features
Figure 9. Global Biopharmaceutical Testing Services Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Biopharmaceutical Testing Services Market Share by Application: 2024 VS 2031
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Others Case Studies
Figure 14. Biopharmaceutical Testing Services Report Years Considered
Figure 15. Global Biopharmaceutical Testing Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Biopharmaceutical Testing Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Biopharmaceutical Testing Services Market Share by Region: 2024 VS 2031
Figure 18. Global Biopharmaceutical Testing Services Market Share by Players in 2024
Figure 19. Global Top Biopharmaceutical Testing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Testing Services as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Biopharmaceutical Testing Services Revenue in 2024
Figure 21. North America Biopharmaceutical Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Biopharmaceutical Testing Services Market Share by Country (2020-2031)
Figure 23. United States Biopharmaceutical Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Biopharmaceutical Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Biopharmaceutical Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Biopharmaceutical Testing Services Market Share by Country (2020-2031)
Figure 27. Germany Biopharmaceutical Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Biopharmaceutical Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Biopharmaceutical Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Biopharmaceutical Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Biopharmaceutical Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Biopharmaceutical Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Biopharmaceutical Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Biopharmaceutical Testing Services Market Share by Region (2020-2031)
Figure 35. China Biopharmaceutical Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Biopharmaceutical Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Biopharmaceutical Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Biopharmaceutical Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Biopharmaceutical Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Biopharmaceutical Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Biopharmaceutical Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Biopharmaceutical Testing Services Market Share by Country (2020-2031)
Figure 43. Mexico Biopharmaceutical Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Biopharmaceutical Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Biopharmaceutical Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Biopharmaceutical Testing Services Market Share by Country (2020-2031)
Figure 47. Turkey Biopharmaceutical Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Biopharmaceutical Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Biopharmaceutical Testing Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Eurofins Scientific Revenue Growth Rate in Biopharmaceutical Testing Services Business (2020-2025)
Figure 51. SGS Revenue Growth Rate in Biopharmaceutical Testing Services Business (2020-2025)
Figure 52. Envigo Revenue Growth Rate in Biopharmaceutical Testing Services Business (2020-2025)
Figure 53. Exova Group Revenue Growth Rate in Biopharmaceutical Testing Services Business (2020-2025)
Figure 54. PPD Inc. Revenue Growth Rate in Biopharmaceutical Testing Services Business (2020-2025)
Figure 55. Pace Analytical Services Revenue Growth Rate in Biopharmaceutical Testing Services Business (2020-2025)
Figure 56. Intertek Group Revenue Growth Rate in Biopharmaceutical Testing Services Business (2020-2025)
Figure 57. DYNALABS Revenue Growth Rate in Biopharmaceutical Testing Services Business (2020-2025)
Figure 58. RD Laboratories Revenue Growth Rate in Biopharmaceutical Testing Services Business (2020-2025)
Figure 59. West Pharmaceutical Services Revenue Growth Rate in Biopharmaceutical Testing Services Business (2020-2025)
Figure 60. Polymer Solutions Revenue Growth Rate in Biopharmaceutical Testing Services Business (2020-2025)
Figure 61. Boston Analytical Revenue Growth Rate in Biopharmaceutical Testing Services Business (2020-2025)
Figure 62. Accuratus Labs Revenue Growth Rate in Biopharmaceutical Testing Services Business (2020-2025)
Figure 63. Microbac Revenue Growth Rate in Biopharmaceutical Testing Services Business (2020-2025)
Figure 64. ARLBioPharma Revenue Growth Rate in Biopharmaceutical Testing Services Business (2020-2025)
Figure 65. Lapuck Laboratories Revenue Growth Rate in Biopharmaceutical Testing Services Business (2020-2025)
Figure 66. BioScreen Revenue Growth Rate in Biopharmaceutical Testing Services Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Biopharmaceutical Testing Services market?
The top companies in the global Biopharmaceutical Testing Services market are Eurofins Scientific、SGS、Envigo.
Related Reports
Biopharmaceutical Testing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Biopharmaceutical Testing Services was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 121
USD 3950.00
(Single User License)
Global Biopharmaceutical Testing Services Market Research Report 2026
The global Biopharmaceutical Testing Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 134
USD 2900.00
(Single User License)
Global Biopharmaceutical Testing Services Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Biopharmaceutical Testing Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 153
USD 4900.00
(Single User License)
Global Biopharmaceutical Testing Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Biopharmaceutical Testing Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 101
USD 4250.00
(Single User License)
Biopharmaceutical Testing Services- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Biopharmaceutical Testing Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 139
USD 3950.00
(Single User License)
Global Biopharmaceutical Testing Services Market Insights, Forecast to 2030
Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.
Published Date: 2024-04-19
Pages: 113
USD 4900.00
(Single User License)
Global Biopharmaceutical Testing Services Market Research Report 2024
Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.
Published Date: 2024-01-17
Pages: 90
USD 2900.00
(Single User License)
Biopharmaceutical Testing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.
Published Date: 2024-01-06
Pages: 131
USD 3950.00
(Single User License)
Biopharmaceutical Testing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Biopharmaceutical Testing Services was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 121
USD 3950.00 (Single User License)Global Biopharmaceutical Testing Services Market Research Report 2026
The global Biopharmaceutical Testing Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 134
USD 2900.00 (Single User License)Global Biopharmaceutical Testing Services Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Biopharmaceutical Testing Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 153
USD 4900.00 (Single User License)Global Biopharmaceutical Testing Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Biopharmaceutical Testing Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 101
USD 4250.00 (Single User License)Biopharmaceutical Testing Services- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Biopharmaceutical Testing Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 139
USD 3950.00 (Single User License)Global Biopharmaceutical Testing Services Market Insights, Forecast to 2030
Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.
Published: 2024-04-19
Pages: 113
USD 4900.00 (Single User License)Global Biopharmaceutical Testing Services Market Research Report 2024
Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.
Published: 2024-01-17
Pages: 90
USD 2900.00 (Single User License)Biopharmaceutical Testing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.
Published: 2024-01-06
Pages: 131
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now